Correlation Between Greenwich Lifesciences and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Greenwich Lifesciences and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Greenwich Lifesciences and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Greenwich Lifesciences and Cue Biopharma, you can compare the effects of market volatilities on Greenwich Lifesciences and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Greenwich Lifesciences with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Greenwich Lifesciences and Cue Biopharma.
Diversification Opportunities for Greenwich Lifesciences and Cue Biopharma
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Greenwich and Cue is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Greenwich Lifesciences and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Greenwich Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Greenwich Lifesciences are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Greenwich Lifesciences i.e., Greenwich Lifesciences and Cue Biopharma go up and down completely randomly.
Pair Corralation between Greenwich Lifesciences and Cue Biopharma
Given the investment horizon of 90 days Greenwich Lifesciences is expected to generate 1.24 times less return on investment than Cue Biopharma. But when comparing it to its historical volatility, Greenwich Lifesciences is 1.7 times less risky than Cue Biopharma. It trades about 0.02 of its potential returns per unit of risk. Cue Biopharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 241.00 in Cue Biopharma on November 29, 2024 and sell it today you would lose (117.00) from holding Cue Biopharma or give up 48.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Greenwich Lifesciences vs. Cue Biopharma
Performance |
| Timeline |
| Greenwich Lifesciences |
| Cue Biopharma |
Greenwich Lifesciences and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Greenwich Lifesciences and Cue Biopharma
The main advantage of trading using opposite Greenwich Lifesciences and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Greenwich Lifesciences position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Greenwich Lifesciences vs. Reviva Pharmaceuticals Holdings | Greenwich Lifesciences vs. Eyenovia | Greenwich Lifesciences vs. Immutep Ltd ADR | Greenwich Lifesciences vs. Anavex Life Sciences |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |